953
Views
2
CrossRef citations to date
0
Altmetric
Reviews

The triple interactions between gut microbiota, mycobiota and host immunity

ORCID Icon, &
Pages 11604-11624 | Published online: 01 Jul 2022

References

  • Aagaard, K., J. Ma, K. M. Antony, R. Ganu, J. Petrosino, and J. Versalovic. 2014. The placenta harbors a unique microbiome. Science Translational Medicine 6 (237):237ra65. doi: 10.1126/scitranslmed.3008599.
  • Alexander, M., and P. J. Turnbaugh. 2020. Deconstructing mechanisms of diet-microbiome-immune interactions. Immunity 53 (2):264–76. doi: 10.1016/j.immuni.2020.07.015.
  • Andersen, K. K., N. M. Strokappe, A. Hultberg, K. Truusalu, I. Smidt, R.-H. Mikelsaar, M. Mikelsaar, T. Verrips, L. Hammarström, and H. Marcotte. 2015. Neutralization of Clostridium difficile Toxin B mediated by engineered Lactobacilli that produce single-domain antibodies. Infection and Immunity 84 (2):395–406. doi: 10.1128/IAI.00870-15.
  • Andersson, J. A., A. G. Peniche, C. L. Galindo, P. Boonma, J. Sha, R. A. Luna, T. C. Savidge, A. K. Chopra, and S. M. Dann. 2020. New host-directed therapeutics for the treatment of clostridioides difficile infection. mBio 11 (2):e00053-20. doi: 10.1128/mBio.00053-20.
  • Ansaldo, E., T. K. Farley, and Y. Belkaid. 2021. Control of immunity by the microbiota. Annual Review of Immunology 39:449–79. doi: 10.1146/annurev-immunol-093019-112348.
  • Atarashi, K., T. Tanoue, M. Ando, N. Kamada, Y. Nagano, S. Narushima, W. Suda, A. Imaoka, H. Setoyama, T. Nagamori, et al. 2015. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163 (2):367–80. doi: 10.1016/j.cell.2015.08.058.
  • Bacher, P., T. Hohnstein, E. Beerbaum, M. Röcker, M. G. Blango, S. Kaufmann, J. Röhmel, P. Eschenhagen, C. Grehn, K. Seidel, et al. 2019. Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans. Cell 176 (6):1340–55.e15. doi: 10.1016/j.cell.2019.01.041.
  • Bandara, H. M. H. N., J. Y. Y. Yau, R. M. Watt, L. J. Jin, and L. P. Samaranayake. 2009. Escherichia coli and its lipopolysaccharide modulate in vitro Candida biofilm formation. Journal of Medical Microbiology 58 (12):1623–31. doi: 10.1099/jmm.0.012989-0.
  • Borody, T. J., and A. Khoruts. 2011. Fecal microbiota transplantation and emerging applications. Nature Reviews. Gastroenterology & Hepatology 9 (2):88–96. doi: 10.1038/nrgastro.2011.244.
  • Boutin, R. C. T., H. Sbihi, R. J. McLaughlin, A. S. Hahn, K. M. Konwar, R. S. Loo, D. Dai, C. Petersen, F. S. L. Brinkman, G. L. Winsor, et al. 2021. Composition and associations of the infant gut fungal microbiota with environmental factors and childhood allergic outcomes. mBio 12 (3):e0339620. doi: 10.1128/mBio.03396-20.
  • Briard, B., T. Fontaine, P. Samir, D. E. Place, L. Muszkieta, R. K. S. Malireddi, R. Karki, S. Christgen, P. Bomme, P. Vogel, et al. 2020. Galactosaminogalactan activates the inflammasome to provide host protection. Nature 588 (7839):688–92. doi: 10.1038/s41586-020-2996-z.
  • Bruno, M., S. Kersten, J. M. Bain, M. Jaeger, D. Rosati, M. D. Kruppa, D. W. Lowman, P. J. Rice, B. Graves, Z. Ma, et al. 2020. Transcriptional and functional insights into the host immune response against the emerging fungal pathogenCandida auris. Nature Microbiology 5 (12):1516–31. doi: 10.1038/s41564-020-0780-3.
  • Bulgasem, B. Y., M. N. Lani, Z. Hassan, W. M. W. Yusoff, and S. G. Fnaish. 2016. Antifungal activity of lactic acid bacteria strains isolated from natural honey against pathogenic Candida Species. Mycobiology 44 (4):302–9. doi: 10.5941/MYCO.2016.44.4.302.
  • Cao, Y., Z. Wang, Y. Yan, L. Ji, J. He, B. Xuan, C. Shen, Y. Ma, S. Jiang, D. Ma, et al. 2021. Enterotoxigenic Bacteroides fragilis promotes intestinal inflammation and malignancy by inhibiting exosomes-packaged miR-149-3p. Gastroenterology 161 (5):1552–66.e12. doi: 10.1053/j.gastro.2021.08.003.
  • Carmen Collado, M., S. Rautava, J. Aakko, E. Isolauri, and S. Salminen. 2016. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Scientific Reports 6:23129. doi: 10.1038/srep23129.
  • Chandra, H., K. K. Sharma, O. H. Tuovinen, X. Sun, and P. Shukla. 2021. Pathobionts: Mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile. Gut Microbes 13 (1):1979882. doi: 10.1080/19490976.2021.1979882.
  • Chang, A. E., J. L. Golob, T. M. Schmidt, D. C. Peltier, C. D. Lao, and M. Tewari. 2021. Targeting the gut microbiome to mitigate immunotherapy-induced colitis in cancer. Trends in Cancer 7 (7):583–93. doi: 10.1016/j.trecan.2021.02.005.
  • Chaput, N., P. Lepage, C. Coutzac, E. Soularue, K. Le Roux, C. Monot, L. Boselli, E. Routier, L. Cassard, M. Collins, et al. 2017. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Annals of Oncology 28 (6):1368–79. doi: 10.1093/annonc/mdx108.
  • Chatterjee, G., S. Negi, S. Basu, J. Faintuch, A. O’Donovan, and P. Shukla. 2022. Microbiome systems biology advancements for natural well-being. The Science of the Total Environment 838 (Pt 2):155915. doi: 10.1016/j.scitotenv.2022.155915.
  • Chehoud, C., L. G. Albenberg, C. Judge, C. Hoffmann, S. Grunberg, K. Bittinger, R. N. Baldassano, J. D. Lewis, F. D. Bushman, and G. D. Wu. 2015. Fungal signature in the gut microbiota of pediatric patients with inflammatory bowel disease. Inflammatory Bowel Diseases 21 (8):1948–56. doi: 10.1097/mib.0000000000000454.
  • Chiaro, T. R., R. Soto, W. Zac Stephens, J. L. Kubinak, C. Petersen, L. Gogokhia, R. Bell, J. C. Delgado, J. Cox, W. Voth, et al. 2017. A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. Science Translational Medicine 9 (380):eaaf9044. doi: 10.1126/scitranslmed.aaf9044.
  • Chien, T., T. Harimoto, B. Kepecs, K. Gray, C. Coker, N. Hou, K. Pu, T. Azad, A. Nolasco, M. Pavlicova, et al. 2021. Enhancing the tropism of bacteria via genetically programmed biosensors. Nature Biomedical Engineering 6 (1):94–104. doi: 10.1038/s41551-021-00772-3.
  • Chikina, A. S., F. Nadalin, M. Maurin, M. San-Roman, T. Thomas-Bonafos, X. V. Li, S. Lameiras, S. Baulande, S. Henri, B. Malissen, et al. 2020. Macrophages maintain epithelium integrity by limiting fungal product absorption. Cell 183 (2):411–28.e16. doi: 10.1016/j.cell.2020.08.048.
  • Chung, Y., Y. Ryu, B. C. An, Y.-S. Yoon, O. Choi, T. Y. Kim, J. Yoon, J. Y. Ahn, H. J. Park, S.-K. Kwon, et al. 2021. A synthetic probiotic engineered for colorectal cancer therapy modulates gut microbiota. Microbiome 9 (1):122. doi: 10.1186/s40168-021-01071-4.
  • de Agueero, M. G., S. C. Ganal-Vonarburg, T. Fuhrer, S. Rupp, Y. Uchimura, H. Li, A. Steinert, M. Heikenwalder, S. Hapfelmeier, U. Sauer, et al. 2016. The maternal microbiota drives early postnatal innate immune development. Science 351 (6279):1296–301. doi: 10.1126/science.aad2571.
  • Doehner, H., D. J. Weisdorf, and C. D. Bloomfield. 2015. Acute myeloid leukemia. The New England Journal of Medicine 373 (12):1136–52. doi: 10.1056/NEJMra1406184.
  • Engevik, M. A., H. A. Danhof, W. Ruan, A. C. Engevik, A. L. Chang-Graham, K. A. Engevik, Z. Shi, Y. Zhao, C. K. Brand, E. S. Krystofiak, et al. 2021. Fusobacterium nucleatum secretes outer membrane vesicles and promotes intestinal inflammation. mBio 12 (2):e02706-20. doi: 10.1128/mBio.02706-20.
  • Fan, D., L. A. Coughlin, M. M. Neubauer, J. Kim, M. S. Kim, X. Zhan, T. R. Simms-Waldrip, Y. Xie, L. V. Hooper, and A. Y. Koh. 2015. Activation of HIF-1 alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nature Medicine 21 (7):808–14. +. doi: 10.1038/nm.3871.
  • Fan, L., Y. Qi, S. Qu, X. Chen, A. Li, M. Hendi, C. Xu, L. Wang, T. Hou, J. Si, et al. 2021. B. adolescentis ameliorates chronic colitis by regulating Treg/Th2 response and gut microbiota remodeling. Gut Microbes 13 (1):1–17. doi: 10.1080/19490976.2020.1826746.
  • Fan, Z., R. P. Ross, C. Stanton, B. Hou, J. Zhao, H. Zhang, B. Yang, and W. Chen. 2021. Lactobacillus casei CCFM1074 alleviates collagen-induced arthritis in rats via balancing Treg/Th17 and modulating the metabolites and gut microbiota. Frontiers in Immunology 12:680073. doi: 10.3389/fimmu.2021.680073.
  • Fei, Y., Z. Chen, S. Han, S. Zhang, T. Zhang, Y. Lu, B. Berglund, H. Xiao, L. Li, and M. Yao. 2021. Role of prebiotics in enhancing the function of next-generation probiotics in gut microbiota. Critical Reviews in Food Science and Nutrition. 1–18. doi: 10.1080/10408398.2021.1958744. PMID: 34323634
  • Fox, P. G., F. Schiavetti, R. Rappuoli, R. M. McLoughlin, and F. Bagnoli. 2021. Staphylococcal protein A induces leukocyte necrosis by complexing with human immunoglobulins. mBio 12 (3):e00899-21. doi: 10.1128/mBio.00899-21.
  • Glassner, K. L., B. P. Abraham, and E. M. M. Quigley. 2020. The microbiome and inflammatory bowel disease. The Journal of Allergy and Clinical Immunology 145 (1):16–27. doi: 10.1016/j.jaci.2019.11.003.
  • Goh, Y. J., R. Barrangou, and T. R. Klaenhammer. 2021. In vivo transcriptome of Lactobacillus acidophilus and colonization impact on murine host intestinal gene expression. mBio 12 (1):e03399-20. doi: 10.1128/mBio.03399-20.
  • Goldman, G. H., Y. Delneste, and N. Papon. 2021. Fungal polysaccharides promote protective immunity. Trends in Microbiology 29 (5):379–81. doi: 10.1016/j.tim.2021.02.004.
  • Goncalves, S. M., C. Duarte-Oliveira, C. F. Campos, V. Aimanianda, R. ter Horst, L. Leite, T. Mercier, P. Pereira, M. Fernández-García, D. Antunes, et al. 2020. Phagosomal removal of fungal melanin reprograms macrophage metabolism to promote antifungal immunity. Nature Communications 11 (1):2282. doi: 10.1038/s41467-020-16120-z.
  • Gopalakrishnan, V., C. N. Spencer, L. Nezi, A. Reuben, M. C. Andrews, T. V. Karpinets, P. A. Prieto, D. Vicente, K. Hoffman, S. C. Wei, et al. 2018. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359 (6371):97–103. doi: 10.1126/science.aan4236.
  • Goubet, A.-G., R. Wheeler, A. Fluckiger, B. Qu, F. Lemaître, K. Iribarren, L. Mondragón, M. Tidjani Alou, E. Pizzato, S. Durand, et al. 2021. Multifaceted modes of action of the anticancer probiotic Enterococcus hirae. Cell Death & Differentiation 28 (7):2276–95. doi: 10.1038/s41418-021-00753-8.
  • Gunsalus, K. T. W., S. N. Tornberg-Belanger, N. R. Matthan, A. H. Lichtenstein, and C. A. Kumamoto. 2016. Manipulation of host diet to reduce gastrointestinal colonization by the opportunistic pathogen Candida albicans. mSphere 1 (1):e00020-15. doi: 10.1128/mSphere.00020-15.
  • Guo, J., C. Ren, X. Han, W. Huang, Y. You, and J. Zhan. 2021. Role of IgA in the early-life establishment of the gut microbiota and immunity: Implications for constructing a healthy start. Gut Microbes 13 (1):1–21. doi: 10.1080/19490976.2021.1908101.
  • Guo, S., W. Yan, S. P. McDonough, N. Lin, K. J. Wu, H. He, H. Xiang, M. Yang, M. A. S. Moreira, and Y.-F. Chang. 2015. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model. Vaccine 33 (13):1586–95. doi: 10.1016/j.vaccine.2015.02.006.
  • Gur, C., Y. Ibrahim, B. Isaacson, R. Yamin, J. Abed, M. Gamliel, J. Enk, Y. Bar-On, N. Stanietsky-Kaynan, S. Coppenhagen-Glazer, et al. 2015. Binding of the Fap2 Protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity 42 (2):344–55. doi: 10.1016/j.immuni.2015.01.010.
  • Hallen-Adams, H. E., and M. J. Suhr. 2017. Fungi in the healthy human gastrointestinal tract. Virulence 8 (3):352–8. doi: 10.1080/21505594.2016.1247140.
  • Hallert, C., I. Bjorck, M. Nyman, A. Pousette, C. Granno, and H. Svensson. 2003. Increasing fecal butyrate in ulcerative colitis patients by diet: Controlled pilot study. Inflammatory Bowel Diseases 9 (2):116–21. doi: 10.1097/00054725-200303000-00005.
  • Han, J.-X., Z.-H. Tao, Y. Qian, C.-Y. Yu, J. Li, Z.-R. Kang, S. Lu, Y. Xie, J. Hong, H. Chen, et al. 2021. ZFP90 drives the initiation of colitis-associated colorectal cancer via a microbiota-dependent strategy. Gut Microbes 13 (1):1–20. doi: 10.1080/19490976.2021.1917269.
  • Hanssen, N. M. J., W. M. de Vos, and M. Nieuwdorp. 2021. Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? Cell Metabolism 33 (6):1098–110. doi: 10.1016/j.cmet.2021.05.005.
  • Hayase, E., and R. R. Jenq. 2021. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer. Genome Medicine 13 (1):107. doi: 10.1186/s13073-021-00923-w.
  • Hedin, C. R., N. E. McCarthy, P. Louis, F. M. Farquharson, S. McCartney, A. J. Stagg, J. O. Lindsay, and K. Whelan. 2021. Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn’s disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease. Clinical Nutrition 40 (8):5009–19. doi: 10.1016/j.clnu.2021.05.033.
  • Henrick, B. M., L. Rodriguez, T. Lakshmikanth, C. Pou, E. Henckel, A. Arzoomand, A. Olin, J. Wang, J. Mikes, Z. Tan, et al. 2021. Bifidobacteria-mediated immune system imprinting early in life. Cell 184 (15):3884–98.e11. doi: 10.1016/j.cell.2021.05.030.
  • Hertel, J., A. Heinken, F. Martinelli, and I. Thiele. 2021. Integration of constraint-based modeling with fecal metabolomics reveals large deleterious effects of Fusobacterium spp. on community butyrate production. Gut Microbes 13 (1):1–23. doi: 10.1080/19490976.2021.1915673.
  • Hoffmann, C., S. Dollive, S. Grunberg, J. Chen, H. Li, G. D. Wu, J. D. Lewis, and F. D. Bushman. 2013. Archaea and fungi of the human gut microbiome: Correlations with diet and bacterial residents. PLoS One. 8 (6):e66019. doi: 10.1371/journal.pone.0066019.
  • Hwang, I. Y., E. Koh, A. Wong, J. C. March, W. E. Bentley, Y. S. Lee, and M. W. Chang. 2017. Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models. Nature Communications 8:15028. doi: 10.1038/ncomms15028.
  • Iliev, I. D., and I. Leonardi. 2017. Fungal dysbiosis: Immunity and interactions at mucosal barriers. Nature Reviews. Immunology 17 (10):635–46. doi: 10.1038/nri.2017.55.
  • Jiang, T. T., T.-Y. Shao, W. X. G. Ang, J. M. Kinder, L. H. Turner, G. Pham, J. Whitt, T. Alenghat, and S. S. Way. 2017. Commensal fungi recapitulate the protective benefits of intestinal bacteria. Cell Host & Microbe 22 (6):809–16.e4. doi: 10.1016/j.chom.2017.10.013.
  • Khoruts, A., C. Staley, and M. J. Sadowsky. 2020. Faecal microbiota transplantation for Clostridioides difficile: Mechanisms and pharmacology. Nature Reviews Gastroenterology & Hepatology 18 (1):67–80. doi: 10.1038/s41575-020-0350-4.
  • Kim, S., Y.-C. Shin, T.-Y. Kim, Y. Kim, Y.-S. Lee, S.-H. Lee, M.-N. Kim, E. O, K. S. Kim, and M.-N. Kweon. 2021. Mucin degrader Akkermansia muciniphila accelerates intestinal stem cell-mediated epithelial development. Gut Microbes 13 (1):1–20. doi: 10.1080/19490976.2021.1892441.
  • Kim, Y.-G., K. G. S. Udayanga, N. Totsuka, J. B. Weinberg, G. Nunez, and A. Shibuya. 2014. Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE(2). Cell Host & Microbe 15 (1):95–102. doi: 10.1016/j.chom.2013.12.010.
  • Kostic, A. D., E. Chun, L. Robertson, J. N. Glickman, C. A. Gallini, M. Michaud, T. E. Clancy, D. C. Chung, P. Lochhead, G. L. Hold, et al. 2013. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe 14 (2):207–15. doi: 10.1016/j.chom.2013.07.007.
  • Lamas, B., M. L. Richard, V. Leducq, H.-P. Pham, M.-L. Michel, G. Da Costa, C. Bridonneau, S. Jegou, T. W. Hoffmann, J. M. Natividad, et al. 2016. CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands. Nature Medicine 22 (6):598–605. doi: 10.1038/nm.4102.
  • Le Roy, T., E. Moens de Hase, M. Van Hul, A. Paquot, R. Pelicaen, M. Régnier, C. Depommier, C. Druart, A. Everard, D. Maiter, et al. 2021. Dysosmobacter welbionis is a newly isolated human commensal bacterium preventing diet-induced obesity and metabolic disorders in mice. Gut 71 (3):534–43. doi: 10.1136/gutjnl-2020-323778.
  • Lee, S.-H., S.-Y. Cho, Y. Yoon, C. Park, J. Sohn, J.-J. Jeong, B.-N. Jeon, M. Jang, C. An, S. Lee, et al. 2021. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice. Nature Microbiology 6 (3):277–88. doi: 10.1038/s41564-020-00831-6.
  • Leonardi, I., X. Li, A. Semon, D. Li, I. Doron, G. Putzel, A. Bar, D. Prieto, M. Rescigno, D. P. B. McGovern, et al. 2018. CX3CR1(+) mononuclear phagocytes control immunity to intestinal fungi. Science 359 (6372):232–6. doi: 10.1126/science.aao1503.
  • Liguori, G., B. Lamas, M. L. Richard, G. Brandi, G. da Costa, T. W. Hoffmann, M. P. Di Simone, C. Calabrese, G. Poggioli, P. Langella, et al. 2016. Fungal dysbiosis in mucosa-associated microbiota of Crohn’s disease patients. Journal of Crohn’s and Colitis 10 (3):296–305. doi: 10.1093/ecco-jcc/jjv209.
  • Li, M., B. C. A. M. van Esch, G. T. M. Wagenaar, J. Garssen, G. Folkerts, and P. A. J. Henricks. 2018. Pro- and anti-inflammatory effects of short chain fatty acids on immune and endothelial cells. European Journal of Pharmacology 831:52–9. doi: 10.1016/j.ejphar.2018.05.003.
  • Li, W., S. Hang, Y. Fang, S. Bae, Y. Zhang, M. Zhang, G. Wang, M. D. McCurry, M. Bae, D. Paik, et al. 2021. A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. Cell Host & Microbe 29:1366–77.e9. doi: 10.1016/j.chom.2021.07.013.
  • Li, X. V., I. Leonardi, and I. D. Iliev. 2019. Gut mycobiota in immunity and inflammatory disease. Immunity 50 (6):1365–79. doi: 10.1016/j.immuni.2019.05.023.
  • Li, X., I. Leonardi, A. Semon, I. Doron, I. H. Gao, G. G. Putzel, Y. Kim, H. Kabata, D. Artis, W. D. Fiers, et al. 2018. Response to Fungal dysbiosis by gut-resident CX3CR1(+) mononuclear phagocytes aggravates allergic airway disease. Cell Host & Microbe 24 (6):847–56.e4. doi: 10.1016/j.chom.2018.11.003.
  • Limon, J. J., J. Tang, D. Li, A. J. Wolf, K. S. Michelsen, V. Funari, M. Gargus, C. Nguyen, P. Sharma, V. I. Maymi, et al. 2019. Malassezia is associated with Crohn’s disease and exacerbates colitis in mouse models. Cell Host & Microbe 25 (3):377–88.e6. doi: 10.1016/j.chom.2019.01.007.
  • Luu, M., Z. Riester, A. Baldrich, N. Reichardt, S. Yuille, A. Busetti, M. Klein, A. Wempe, H. Leister, H. Raifer, et al. 2021. Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer. Nature Communications 12 (1):4077. doi: 10.1038/s41467-021-24331-1.
  • Mager, L. F., R. Burkhard, N. Pett, N. C. A. Cooke, K. Brown, H. Ramay, S. Paik, J. Stagg, R. A. Groves, M. Gallo, et al. 2020. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science 369 (6510):1481–9. +. doi: 10.1126/science.abc3421.
  • Malard, F., A. Vekhoff, S. Lapusan, F. Isnard, E. D’incan-Corda, J. Rey, C. Saillard, X. Thomas, S. Ducastelle-Lepretre, E. Paubelle, et al. 2021. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients. Nature Communications 12 (1):3084. doi: 10.1038/s41467-021-23376-6.
  • Mathewson, N. D., R. Jenq, A. V. Mathew, M. Koenigsknecht, A. Hanash, T. Toubai, K. Oravecz-Wilson, S.-R. Wu, Y. Sun, C. Rossi, et al. 2016. Gut microbiome-derived metabolites modulate intestinal epithelial cell damage and mitigate graft-versus-host disease. Nature Immunology 17 (5):505–13. doi: 10.1038/ni.3400.
  • Matson, V., J. Fessler, R. Bao, T. Chongsuwat, Y. Zha, M.-L. Alegre, J. J. Luke, and T. F. Gajewski. 2018. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359 (6371):104–8. doi: 10.1126/science.aao3290.
  • Mazmanian, S. K., J. L. Round, and D. L. Kasper. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (7195):620–5. doi: 10.1038/nature07008.
  • McCoubrey, L. E., S. Gaisford, M. Orlu, and A. W. Basit. 2021. Predicting drug-microbiome interactions with machine learning. Biotechnology Advances. 54:107797. doi: 10.1016/j.biotechadv.2021.107797.
  • McCoy, K. D., and L. F. Mager. 2021. Impact of the microbiome on tumor immunity. Current Opinion in Immunology 69:39–46. doi: 10.1016/j.coi.2021.01.002.
  • McGeachy, M. J., D. J. Cua, and S. L. Gaffen. 2019. The IL-17 family of cytokines in health and disease. Immunity 50 (4):892–906. doi: 10.1016/j.immuni.2019.03.021.
  • Montalban-Arques, A., E. Katkeviciute, P. Busenhart, A. Bircher, J. Wirbel, G. Zeller, Y. Morsy, L. Borsig, J. F. Glaus Garzon, A. Müller, et al. 2021. Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors. Cell Host & Microbe 29:1573–88.e7. doi: 10.1016/j.chom.2021.08.001.
  • Morita, N., E. Umemoto, S. Fujita, A. Hayashi, J. Kikuta, I. Kimura, T. Haneda, T. Imai, A. Inoue, H. Mimuro, et al. 2019. GPR31-dependent dendrite protrusion of intestinal CX3CR1(+) cells by bacterial metabolites. Nature 566 (7742):110–4. doi: 10.1038/s41586-019-0884-1.
  • Moyes, D. L., D. Wilson, J. P. Richardson, S. Mogavero, S. X. Tang, J. Wernecke, S. Höfs, R. L. Gratacap, J. Robbins, M. Runglall, et al. 2016. Candidalysin is a fungal peptide toxin critical for mucosal infection. Nature 532 (7597):64. doi:10.1038. /nature17625
  • Mu, Q., B. K. Swartwout, M. Edwards, J. Zhu, G. Lee, K. Eden, X. Cabana-Puig, D. K. McDaniel, J. Mao, and L. Abdelhamid, et al. 2021. Regulation of neonatal IgA production by the maternal microbiota. Proceedings of the National Academy of Sciences of the United States of America 118 (9):e2015691118. doi: 10.1073/pnas.2015691118.
  • Newsome, R. C., J. Gauthier, M. C. Hernandez, G. E. Abraham, T. O. Robinson, H. B. Williams, M. Sloan, A. Owings, H. Laird, T. Christian, et al. 2021. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes 13 (1):1–15. doi: 10.1080/19490976.2021.1926840.
  • Nosho, K., Y. Sukawa, Y. Adachi, M. Ito, K. Mitsuhashi, H. Kurihara, S. Kanno, I. Yamamoto, K. Ishigami, H. Igarashi, et al. 2016. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer. World Journal of Gastroenterology 22 (2):557–66. doi: 10.3748/wjg.v22.i2.557.
  • Orberg, E. T., H. Fan, A. J. Tam, C. M. Dejea, C. E. Destefano Shields, S. Wu, L. Chung, B. B. Finard, X. Wu, P. Fathi, et al. 2017. The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunology 10 (2):421–33. doi: 10.1038/mi.2016.53.
  • Oster, P., L. Vaillant, E. Riva, B. McMillan, C. Begka, C. Truntzer, C. Richard, M. M. Leblond, M. Messaoudene, E. Machremi, et al. 2021. Helicobacter pylori infection has a detrimental impact on the efficacy of cancer immunotherapies. Gut 71 (3):457–66. doi: 10.1136/gutjnl-2020-323392.
  • Pang, B., H. Jin, N. Liao, J. Li, C. Jiang, D. Shao, and J. Shi. 2021. Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. Food & Function 12 (11):5171–86. doi: 10.1039/D0FO03479G.
  • Panpetch, W., N. Somboonna, M. Palasuk, P. Hiengrach, M. Finkelman, S. Tumwasorn, and A. Leelahavanichkul. 2019. Oral Candida administration in a Clostridium difficile mouse model worsens disease severity but is attenuated by Bifidobacterium. Plos ONE 14 (1):e0210798. doi: 10.1371/journal.pone.0210798.
  • Peng, L., Z.-R. Li, R. S. Green, I. R. Holzman, and J. Lin. 2009. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. The Journal of Nutrition 139 (9):1619–25. doi: 10.3945/jn.109.104638.
  • Petrova, M. I., G. Reid, and J. A. Ter Haar. 2021. Lacticaseibacillus rhamnosus GR-1, a.k.a. Lactobacillus rhamnosus GR-1: Past and Future Perspectives. Trends in Microbiology 29 (8):747–61. doi: 10.1016/j.tim.2021.03.010.
  • Radojević, D., S. Tomić, D. Mihajlović, M. Tolinački, B. Pavlović, D. Vučević, S. Bojić, N. Golić, M. Čolić, and J. Đokić. 2021. Fecal microbiota composition associates with the capacity of human peripheral blood monocytes to differentiate into immunogenic dendritic cells in vitro. Gut Microbes 13 (1):1–20. doi: 10.1080/19490976.2021.1921927.
  • Richardson, J. P., H. M. E. Willems, D. L. Moyes, S. Shoaie, K. S. Barker, S. L. Tan, G. E. Palmer, B. Hube, J. R. Naglik, and B. M. Peters. 2018. Candidalysin drives epithelial signaling, neutrophil recruitment, and immunopathology at the vaginal mucosa. Infection and Immunity 86 (2):e00645-17. doi: 10.1128/IAI.00645-17.
  • Round, J. L., and S. K. Mazmanian. 2010. Inducible Foxp(3+) regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences of the United States of America 107 (27):12204–9. doi: 10.1073/pnas.0909122107.
  • Rubio-Del-Campo, A., R. Gozalbo-Rovira, E. M. Moya-Gonzalvez, J. Alberola, J. Rodriguez-Diaz, and M. J. Yebra. 2021. Infant gut microbiota modulation by human milk disaccharides in humanized microbiome mice. Gut Microbes 13 (1):1–20. doi: 10.1080/19490976.2021.1914377.
  • Saha, S., K. Mara, D. S. Pardi, and S. Khanna. 2021. Long-term safety of fecal microbiota transplantation for recurrent clostridioides difficile infection. Gastroenterology 160 (6):1961–9.e1963. doi: 10.1053/j.gastro.2021.01.010.
  • Salaris, C., M. Scarpa, M. Elli, A. Bertolini, S. Guglielmetti, F. Pregliasco, P. Brun, and I. Castagliuolo. 2021. Lacticaseibacillus paracasei DG enhances the lactoferrin anti-SARS-CoV-2 response in Caco-2 cells. Gut Microbes 13 (1):1961970. doi: 10.1080/19490976.2021.1961970.
  • Sen, P., A. Molinero-Perez, K. J. O’Riordan, C. P. McCafferty, K. D. O’Halloran, and J. F. Cryan. 2021. Microbiota and sleep: Awakening the gut feeling. Trends in Molecular Medicine 27 (10):935–45. doi: 10.1016/j.molmed.2021.07.004.
  • Sender, R., S. Fuchs, and R. Milo. 2016. Revised estimates for the number of human and bacteria cells in the body. PLOS Biology 14 (8):e1002533. doi: 10.1371/journal.pbio.1002533.
  • Shao, T.-Y., W. X. G. Ang, T. T. Jiang, F. S. Huang, H. Andersen, J. M. Kinder, G. Pham, A. R. Burg, B. Ruff, T. Gonzalez, et al. 2019. Commensal Candida albicans positively calibrates systemic Th17 immunological responses. Cell Host & Microbe 25 (3):404–17.e6. doi: 10.1016/j.chom.2019.02.004.
  • Shiao, S. L., K. M. Kershaw, J. J. Limon, S. You, J. Yoon, E. Y. Ko, J. Guarnerio, A. A. Potdar, D. P. McGovern, S. Bose, et al. 2021. Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy. Cancer Cell 39 (9):1202–13.e6. doi: 10.1016/j.ccell.2021.07.002.
  • Si, W., H. Liang, J. Bugno, Q. Xu, X. Ding, K. Yang, Y. Fu, R. R. Weichselbaum, X. Zhao, and L. Wang. 2021. Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade. Gut 71 (3):521–33. doi: 10.1136/gutjnl-2020-323426.
  • Sivan, A., L. Corrales, N. Hubert, J. B. Williams, K. Aquino-Michaels, Z. M. Earley, F. W. Benyamin, Y. M. Lei, B. Jabri, M.-L. Alegre, et al. 2015. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (6264):1084–9. doi: 10.1126/science.aac4255.
  • Smith, M. I., T. Yatsunenko, M. J. Manary, I. Trehan, R. Mkakosya, J. Cheng, A. L. Kau, S. S. Rich, P. Concannon, J. C. Mychaleckyj, et al. 2013. Gut microbiomes of Malawian Twin Pairs discordant for Kwashiorkor. Science 339 (6119):548–54. doi: 10.1126/science.1229000.
  • Sokol, H., V. Leducq, H. Aschard, H.-P. Pham, S. Jegou, C. Landman, D. Cohen, G. Liguori, A. Bourrier, I. Nion-Larmurier, et al. 2017. Fungal microbiota dysbiosis in IBD. Gut 66 (6):1039–48. doi: 10.1136/gutjnl-2015-310746.
  • Song, X., X. Sun, S. F. Oh, M. Wu, Y. Zhang, W. Zheng, N. Geva-Zatorsky, R. Jupp, D. Mathis, C. Benoist, et al. 2020. Microbial bile acid metabolites modulate gut ROR gamma(+) regulatory T cell homeostasis. Nature 577 (7790):410. doi: 10.1038/s41586-019-1865-0.
  • Sovran, B., J. Planchais, S. Jegou, M. Straube, B. Lamas, J. M. Natividad, A. Agus, L. Dupraz, J. Glodt, G. Da Costa, et al. 2018. Enterobacteriaceae are essential for the modulation of colitis severity by fungi. Microbiome 6 (1):152. doi: 10.1186/s40168-018-0538-9.
  • Spreckels, J. E., and A. Zhernakova. 2021. Milk and bugs educate infant immune systems. Immunity 54 (8):1633–5. doi: 10.1016/j.immuni.2021.07.013.
  • Sun, X., Y. Cui, Y. Su, Z. Gao, X. Diao, J. Li, X. Zhu, D. Li, Z. Li, C. Wang, et al. 2021. Dietary fiber ameliorates lipopolysaccharide-induced intestinal barrier function damage in piglets by modulation of intestinal microbiome. mSystems 6 (2):e01374-20. doi: 10.1128/mSystems.01374-20.
  • Swift, C. L., K. B. Louie, B. P. Bowen, H. M. Olson, S. O. Purvine, A. Salamov, S. J. Mondo, K. V. Solomon, A. T. Wright, T. R. Northen, et al. 2021. Anaerobic gut fungi are an untapped reservoir of natural products. Proc Natl Acad Sci U S A 118 (18):e2019855118. doi: 10.1073/pnas.2019855118.
  • Tanoue, T., S. Morita, D. R. Plichta, A. N. Skelly, W. Suda, Y. Sugiura, S. Narushima, H. Vlamakis, I. Motoo, K. Sugita, et al. 2019. A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature 565 (7741):600–5. doi: 10.1038/s41586-019-0878-z.
  • Taylor, M., and N. M. Vega. 2021. Host immunity alters community ecology and stability of the microbiome in a Caenorhabditis elegans model. mSystems 6 (2):e00608-20. doi: 10.1128/mSystems.00608-20.
  • Tso, G. H. W., J. A. Reales-Calderon, A. S. M. Tan, X. Sem, G. T. T. Le, T. G. Tan, G. C. Lai, K. G. Srinivasan, M. Yurieva, W. Liao, et al. 2018. Experimental evolution of a fungal pathogen into a gut symbiont. Science 362 (6414):589–95. doi: 10.1126/science.aat0537.
  • Tun, H. M., Y. Peng, B. Chen, T. B. Konya, N. P. Morales-Lizcano, R. Chari, C. J. Field, D. S. Guttman, A. B. Becker, P. J. Mandhane, et al. 2021. Ethnicity associations with food sensitization are mediated by gut microbiota development in the first year of life. Gastroenterology 161 (1):94–106. doi: 10.1053/j.gastro.2021.03.016.
  • van der Lelie, D., A. Oka, S. Taghavi, J. Umeno, T.-J. Fan, K. E. Merrell, S. D. Watson, L. Ouellette, B. Liu, M. Awoniyi, et al. 2021. Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis. Nature Communications 12 (1):3105. doi: 10.1038/s41467-021-23460-x.
  • Verma, A. H., J. P. Richardson, C. Zhou, B. M. Coleman, D. L. Moyes, J. Ho, A. R. Huppler, K. Ramani, M. J. McGeachy, I. A. Mufazalov, et al. 2017. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Science Immunology 2 (17):eaam8834. doi: 10.1126/sciimmunol.aam8834.
  • Vetizou, M., J. M. Pitt, R. Daillère, P. Lepage, N. Waldschmitt, C. Flament, S. Rusakiewicz, B. Routy, M. P. Roberti, C. P. M. Duong, et al. 2015. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (6264):1079–84. doi: 10.1126/science.aad1329.
  • Viaud, S., F. Saccheri, G. Mignot, T. Yamazaki, R. Daillère, D. Hannani, D. P. Enot, C. Pfirschke, C. Engblom, M. J. Pittet, et al. 2013. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science, 342 (6161):971–6. doi: 10.1126/science.1240537.
  • Wang, J., C. Xu, Q. Sun, J. Xu, Y. Chai, G. Berg, T. Cernava, Z. Ma, and Y. Chen. 2021. Post-translational regulation of autophagy is involved in intra-microbiome suppression of fungal pathogens. Microbiome 9 (1):131. doi: 10.1186/s40168-021-01077-y.
  • Wang, Y., D. H. Wiesnoski, B. A. Helmink, V. Gopalakrishnan, K. Choi, H. L. DuPont, Z.-D. Jiang, H. Abu-Sbeih, C. A. Sanchez, C.-C. Chang, et al. 2018. Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. Nature Medicine 24 (12):1804–8. doi: 10.1038/s41591-018-0238-9.
  • Wastyk, H. C., G. K. Fragiadakis, D. Perelman, D. Dahan, B. D. Merrill, F. B. Yu, M. Topf, C. G. Gonzalez, W. Van Treuren, S. Han, et al. 2021. Gut-microbiota-targeted diets modulate human immune status. Cell 184 (16):4137–53.e14. doi: 10.1016/j.cell.2021.06.019.
  • Wheeler, M. L., J. J. Limon, A. S. Bar, C. A. Leal, M. Gargus, J. Tang, J. Brown, V. A. Funari, H. L. Wang, T. R. Crother, et al. 2016. Immunological consequences of intestinal fungal dysbiosis. Cell Host & Microbe 19 (6):865–73. doi: 10.1016/j.chom.2016.05.003.
  • Whibley, N., A. Tucci, and F. Powrie. 2019. Regulatory T cell adaptation in the intestine and skin. Nature Immunology 20 (4):386–96. doi: 10.1038/s41590-019-0351-z.
  • Wong, S. Y., and K. Cadwell. 2018. There was collusion: Microbes in inflammatory bowel disease. PLoS Pathogens 14 (9):e1007215. doi: 10.1371/journal.ppat.1007215.
  • Wong, S. H., L. Zhao, X. Zhang, G. Nakatsu, J. Han, W. Xu, X. Xiao, T. N. Kwong, H. Tsoi, W. K. Wu, et al. 2017. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology 153 (6):1621–33.e6. doi: 10.1053/j.gastro.2017.08.022.
  • Wu, X., Y. Xia, F. He, C. Zhu, and W. Ren. 2021. Intestinal mycobiota in health and diseases: From a disrupted equilibrium to clinical opportunities. Microbiome 9 (1):60. doi: 10.1186/s40168-021-01024-x.
  • Yang, B., M. Ding, Y. Chen, F. Han, C. Yang, J. Zhao, P. Malard, C. Stanton, R. P. Ross, H. Zhang, et al. 2021. Development of gut microbiota and bifidobacterial communities of neonates in the first 6 weeks and their inheritance from mother. Gut Microbes 13 (1):1–13. doi: 10.1080/19490976.2021.1908100.
  • Yang, M., Y. Yang, Q. He, P. Zhu, M. Liu, J. Xu, and M. Zhao. 2021. Intestinal microbiota-A promising target for antiviral therapy? Frontiers in Immunology 12:676232. doi: 10.3389/fimmu.2021.676232.
  • Yoon, H. S., C. H. Cho, M. S. Yun, S. J. Jang, H. J. You, J-h. Kim, D. Han, K. H. Cha, S. H. Moon, K. Lee, et al. 2021. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nature Microbiology 6 (5):563–73. doi: 10.1038/s415.
  • York, A. 2019. FMT in the clinic. Nature Reviews Microbiology 17 (3):127. doi: 10.1038/s41579-019-0157-x.
  • Yu, L.-X., and R. F. Schwabe. 2017. The gut microbiome and liver cancer: Mechanisms and clinical translation. Nature Reviews. Gastroenterology & Hepatology 14 (9):527–39. doi: 10.1038/nrgastro.2017.72.
  • Zelante, T., R. G. Iannitti, C. Cunha, A. De Luca, G. Giovannini, G. Pieraccini, R. Zecchi, C. D’Angelo, C. Massi-Benedetti, F. Fallarino, et al. 2013. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39 (2):372–85. doi: 10.1016/j.immuni.2013.08.003.
  • Zhang, T., G. Lu, Z. Zhao, Y. Liu, Q. Shen, P. Li, Y. Chen, H. Yin, H. Wang, C. Marcella, et al. 2020. Washed microbiota transplantation vs. manual fecal microbiota transplantation: Clinical findings, animal studies and in vitro screening. Protein & Cell 11 (4):251–66. doi: 10.1007/s13238-019-00684-8.
  • Zhao, Y., M. Cheng, L. Zou, L. Yin, C. Zhong, Y. Zha, X. Zhu, L. Zhang, K. Ning, and J. Han. 2021. Hidden link in gut-joint axis: Gut microbes promote rheumatoid arthritis at early stage by enhancing ascorbate degradation. Gut 71 (5):1041–3. doi: 10.1136/gutjnl-2021-325209.
  • Zheng, Y., T. Wang, X. Tu, Y. Huang, H. Zhang, D. Tan, W. Jiang, S. Cai, P. Zhao, R. Song, et al. 2019. Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with updates hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer 7 (1):193. doi: 10.1186/s40425-019-0650-9.
  • Zhou, C. B., Y. L. Zhou, and J. Y. Fang. 2021. Gut microbiota in cancer immune response and immunotherapy. Trends Cancer. 7(7):647–660. doi: 10.1016/j.trecan.2021.01.010.
  • Zuo, F., and H. Marcotte. 2021. Advancing mechanistic understanding and bioengineering of probiotic lactobacilli and bifidobacteria by genome editing. Current Opinion in Biotechnology 70:75–82. doi: 10.1016/j.copbio.2020.12.015.
  • Zuo, T., S. H. Wong, C. P. Cheung, K. Lam, R. Lui, K. Cheung, F. Zhang, W. Tang, J. Y. L. Ching, J. C. Y. Wu, et al. 2018. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection. Nature Communications 9 (1):3663. doi: 10.1038/s41467-018-06103-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.